Angiodynamics (ANGO) Total Non-Current Liabilities (2012 - 2026)

Angiodynamics has reported Total Non-Current Liabilities for 15 years, with the latest figure at $70.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 14.06% year-over-year to $70.6 million; the trailing twelve-month figure through Feb 2026 stood at $70.6 million (down 14.06% YoY), and the FY2025 full-year result was $80.3 million, down 16.39% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $70.6 million, down from $76.3 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $151.0 million in Q2 2023, with the low at $63.2 million in Q3 2023.
• Historically, Total Non-Current Liabilities has averaged $100.8 million across 5 years, with a median of $92.9 million in 2024.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities jumped 39.48% — and 2023, when it tumbled 54.74%.
• Angiodynamics' Total Non-Current Liabilities stood at $146.7 million in 2022, then plunged by 32.94% to $98.4 million in 2023, then decreased by 5.56% to $92.9 million in 2024, then retreated by 17.9% to $76.3 million in 2025, then fell by 7.44% to $70.6 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $70.6 million (Q1 2026), $76.3 million (Q4 2025), and $72.6 million (Q3 2025), per Business Quant data.